In chronic myeloid leukemia (CML) cells expressing BCR-ABL1, IL-33 increases the proliferation and helps leukemia cells exert resistance to the inhibitor imatinib (13). The gene discussed is IL33; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.